American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

Christine Seidman, MD, director of the cardiovascular genetics program, cardiovascular medicine specialist, Brigham & Women’s Hospital, discusses the use of genetics to crack the code of cardiovascular diseases to enable earlier prevention and interventions. She was named the winner of the American Heart Association (AHA) 2022 Research Achievement Award, AHA's highest honor.

VIDEO: Using genetics in cardiology to enable earlier interventions

Christine Seidman, MD, director of the cardiovascular genetics program at Brigham & Women’s Hospital, spoke to us about using genetics to crack the code of cardiovascular disease. 

hospital ward

Why cardiologists should pay close attention to rehospitalizations after TAVR or SAVR

A new analysis in Circulation: Cardiovascular Interventions examined rehospitalization rates after AVR, noting that they are consistently associated with worse outcomes and a higher risk of patient mortality.

Patients with especially high blood pressure may want to limit how much coffee they drink

Researchers explored nearly 20 years of data from more than 18,000 patients, sharing their findings in the Journal of the American Heart Association.

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

VIDEO: The importance of assessing TAVR valve durability

Brian Lindman, MD, discusses the tracking of TAVR devices for signs of deterioration and how to assess long-term durability.

Takeshi Tsuda, MD, pediatric cardiologist, Nemours Children’s Health, Delaware, discusses evaluation of cardio-toxicity in pediatric cancer patients. He presented a study at American Heart Association (AHA) 2022 meeting that hoped to show the use of cardiac stress testing on children would indicate which patients would see more toxicity from chemotherapy agents. #AHA #AHA22

VIDEO: Identifying cardiotoxicity in young cancer patients

Pediatric cardiologist Takeshi Tsuda, MD, discussed the evaluation of cardiotoxicity in young cancer patients at the American Heart Association (AHA) 2022 meeting.

VIDEO: The need to develop the cardiology workforce

ACC President Edward T.A. Fry, MD, explains the need to better develop the cardiology workforce as the subspecialty faces a looming shortage of cardiologists. 

Thumbnail

World’s leading cardiology groups say it is time to rethink RCTs

The American College of Cardiology, American Heart Association, European Society of Cardiology and World Heart Federation all collaborated on a joint statement aimed at updating the rules and regulations associated with randomized clinical trials

Juan Granada discusses new cardiac technology AHA22.

VIDEO: 2 key technologies to rapidly advance cardiovascular care

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.